HIA
HALO icon

HFM Investment Advisors’s Halozyme HALO Stock Holding History

HFM Investment Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$452 Sell
7
-18
-72% -$1.27K ﹤0.01% 714
2025
Q4 		$1.68K Buy
25
+18
+257% +$1.21K ﹤0.01% 326
2025
Q3 		$513 Hold
7
– – ﹤0.01% 649
2025
Q2 		$364 Buy
7
+4
+133% +$228 ﹤0.01% 774
2025
Q1 		$192 Buy
+3
New +$174 ﹤0.01% 645

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HFM Investment Advisors's HALO Position: Q1 2026 in Review

HFM Investment Advisors reduced its Halozyme (HALO) stake by 72% in Q1 2026, selling an estimated $1.27K and leaving 7 shares worth $452. The position accounts for ﹤0.01% of the portfolio, ranked #714.

HFM Investment Advisors first reported a position in HALO in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.68K in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • HFM Investment Advisors held 7 shares of Halozyme worth $452 as of Q1 2026.
  • HFM Investment Advisors sold 18 Halozyme shares in Q1 2026, an estimated $1.27K.
  • Halozyme made up ﹤0.01% of HFM Investment Advisors's portfolio in Q1 2026, its #714 holding.
  • HFM Investment Advisors first reported a position in Halozyme in Q1 2025 and has held it in 5 quarters since.
  • HFM Investment Advisors's Halozyme position peaked at $1.68K in Q4 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on HFM Investment Advisors's 13F filing for Q1 2026, filed 1 May 2026.